{
  "scenario_name": "Helios BioTech FY26 Strategic Planning Offsite",
  "company_context": "Helios BioTech, a $1.2B publicly\u2011traded biotechnology company focused on next\u2011generation gene\u2011editing therapies for rare genetic disorders. The executive team includes the CEO, CFO, COO, CMO, CRO, Chief Strategy Officer, VP of R&D, VP of Commercial, and CHRO. The offsite is the first full\u2011team strategic planning session since the Series\u202fD financing round and will set the direction for FY26 and beyond.",
  "meeting_event_details": "June 10\u201112, 2025 (3 days). Arrival & welcome dinner June\u202f10 at 6:00\u202fPM, full agenda runs 8:30\u202fAM\u20135:30\u202fPM each day. Location: Aspen Mountain Resort, Aspen, Colorado (Conference Center\u202fA, rooms 101\u2011104, plus breakout spaces). All meals, transportation from Denver International Airport, and a one\u2011night team\u2011building ski activity are included.",
  "stakeholders": [
    "Dr. Elena Ramirez \u2013 Chief Executive Officer (overall sponsor, final decision\u2011maker)",
    "James Liu \u2013 Chief Financial Officer (budget, capital allocation)",
    "Maya Patel \u2013 Chief Operating Officer (execution roadmap)",
    "Dr. Priya Nair \u2013 Chief Medical Officer (pipeline prioritization)",
    "Dr. Carlos Ortega \u2013 Chief Research Officer (R&D strategy)",
    "Laura Chen \u2013 Chief Commercial Officer (market entry & partnership strategy)",
    "Sanjay Patel \u2013 Chief Strategy Officer (facilitates scenario planning)",
    "Aisha Khan \u2013 Chief Human Resources Officer (talent & culture alignment)",
    "Dr. Maya Patel \u2013 External Facilitator, Senior Partner, StrategyBridge (neutral process owner)",
    "External Advisors: Dr. Robert Stein (Regulatory), Ms. Vanessa Brooks (M&A counsel)"
  ],
  "deliverables": [
    "Executive Summary Deck (10 slides) outlining FY26 vision, strategic priorities, and OKRs",
    "Capital Allocation Model showing $200M investment plan across R&D, commercialization, and M&A",
    "Go/No\u2011Go decision matrix for Phase\u202fIII trial of Hemophilia\u2011B gene therapy",
    "Competitive Landscape Heatmap with 5\u2011year trend projections",
    "Revised 5\u2011Year Vision Statement and Mission Alignment Document",
    "Action\u2011Item Register with owners, milestones, and owners for each strategic initiative",
    "Communication Playbook for post\u2011offsite rollout (board brief, employee town\u2011hall, investor update)"
  ],
  "success_criteria": [
    "All FY26 OKRs are defined, quantified, and assigned to owners within 48\u202fhours of the offsite",
    "Capital allocation model approved by CFO and board liaison by end of day 3",
    "Phase\u202fIII go/no\u2011go decision documented and signed off by CEO and CRO",
    "Strategic partnership shortlist (minimum 3 candidates) agreed upon with evaluation criteria",
    "Post\u2011offsite communication plan executed: board brief sent within 24\u202fhours, employee town\u2011hall scheduled within 5 business days, investor update drafted within 7 days",
    "Participant satisfaction \u2265\u202f90\u202f% (post\u2011event survey) and perceived clarity of direction \u2265\u202f8/10"
  ],
  "constraints": [
    "Total offsite budget capped at $250,000 (venue, travel, facilitation, materials)",
    "All pre\u2011work (market research, financial analysis, competitor dossiers) must be submitted to the facilitator by May\u202f20,\u202f2025",
    "Regulatory filing deadlines (e.g., IND amendment due July\u202f15) limit the amount of time that can be allocated to new trial design discussions",
    "Key external advisors (Regulatory, M&A counsel) are only available for 4\u202fhours total across the three days",
    "COVID\u201119 travel restrictions require all participants to be fully vaccinated and present a negative test within 72\u202fhours of arrival"
  ],
  "workback_prompt": "Create a detailed work\u2011back plan for the Helios BioTech FY26 Strategic Planning Offsite (June\u202f10\u201112,\u202f2025). Include all pre\u2011work deliverables (market research, financial models, competitor analysis), facilitator preparation, logistics (travel, venue booking, catering), agenda development, breakout session planning, decision\u2011making checkpoints, post\u2011offsite communication rollout, and risk mitigation steps. Provide timelines, owners, dependencies, and milestones leading up to the offsite and through the first 30\u202fdays after the event, ensuring the success criteria and constraints listed in the scenario are met.",
  "meeting_type": "Strategic Planning Offsite",
  "meeting_type_key": "9_strategic_offsite",
  "scenario_number": 3,
  "horizon": "T-90",
  "complexity": "Very High",
  "generated_at": "2025-11-17T07:46:20.308917"
}